Balkan Journal of Medical Genetics

PHENOTYPIC VARIABILITY OF COWDEN SYNDROME WITHIN A SINGLE FAMILY: IMPACT ON DIAGNOSIS, MANAGEMENT AND GENETIC COUNSELLING
Ilic N1, Mitrovic N2, Radeta R3, Krasić S4,5, Vukomanović V4,5, Samardzija G2, Vasic M6, Vlahovic A5,6, Sarajlija A1,5
*Corresponding Author: *Corresponding Author: Ass. Prof. Dr. Adrijan Sarajlija MD, PhD, Clinical Genetics Outpatient Clinic, Mother and Child Health Care Institute “Dr Vukan Čupić”, Radoja Dakića 6-8, 11070 Novi Beograd, Serbia; University of Belgrade, Faculty of Medicine, Belgrade, Serbia; e-mail: adrijans2004@yahoo.com
page: 95

REFERENCE

1. Gammon A, Jasperson K, Champine M. Genetic basis of Cowden syndrome and its implications for clini- cal practice and risk management. Appl Clin Genet. 2016;9:83–92. 2. Zeng N, Bayan JA, He L, Stiles B. The Role of PTEN in β-Cell Growth. Open Endocrinol J. 2010;4:23–32. 3. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid can- cer syndrome. Nat Genet. 1997 May;16(1):64–7. 4. Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013 Nov 6;105(21):1607–16. 5. Takayama T, Muguruma N, Igarashi M, Ohsumi S, Oka S, Kakuta F, et al. Clinical Guidelines for Diagnosis and Management of Cowden Syndrome/ PTEN Hamartoma Tumor Syndrome in Children and Adults―Secondary Publication. J Anus Rectum Co- lon. 2023 Oct 25;7(4):284–300. 6. Rademacher S, Eickholt BJ. PTEN in Autism and Neurodevelopmental Disorders. Cold Spring Harb Perspect Med. 2019 Nov 1;9(11):a036780. 7. Cummings K, Watkins A, Jones C, Dias R, Welham A. Behavioural and psychological features of PTEN mutations: a systematic review of the literature and meta-analysis of the prevalence of autism spectrum disorder characteristics. J Neurodev Disord. 2022 Jan 4;14(1):1. 8. Kieselova K, Santiago F, Henrique M, Cunha MF. Multiple sclerotic fibromas of the skin: an important clue for the diagnosis of Cowden syndrome. BMJ Case Rep. 2017 Aug 28;2017:bcr2017221695, bcr- 2017–221695. 9. Lim A, Ngeow J. The Skin in Cowden Syndrome. Front Med (Lausanne). 2021;8:658842. 10. Ponti G, Pellacani G, Seidenari S, Pollio A, Mus- catello U, Tomasi A. Cancer-associated genoder- matoses: skin neoplasms as clues to hereditary tumor syndromes. Crit Rev Oncol Hematol. 2013 Mar;85(3):239–56. 11. Caliskan A, Kohlmann WK, Affolter KE, Downs- Kelly E, Kanth P, Bronner MP. Intramucosal lipo- mas of the colon implicate Cowden syndrome. Mod Pathol. 2018 Apr;31(4):643–51. 12. Carneiro F. Familial and hereditary gastric cancer, an overview. Best Pract Res Clin Gastroenterol. 2022;58–59:101800. 13. Tan WH, Baris HN, Burrows PE, Robson CD, Alo- mari AI, Mulliken JB, et al. The spectrum of vascular anomalies in patients with PTEN mutations: implica- tions for diagnosis and management. J Med Genet. 2007 Sep;44(9):594–602. 14. Yehia L, Keel E, Eng C. The Clinical Spectrum of PTEN Mutations. Annu Rev Med. 2020 Jan 27;71:103–16. 15. Dragoo DD, Taher A, Wong VK, Elsaiey A, Consul N, Mahmoud HS, et al. PTEN Hamartoma Tumor Syn- drome/Cowden Syndrome: Genomics, Oncogenesis, and Imaging Review for Associated Lesions and Ma- lignancy. Cancers (Basel). 2021 Jun 22;13(13):3120. 16. Kingdom R, Wright CF. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Popu- lation Cohorts. Front Genet. 2022 Jul 25;13:920390. 17. Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012 Jan 15;18(2):400–7. 18. Higuchi D, Matsuura T, Takamine E, Hosokawa M, Kobori K, Ikeda S, et al. [Ovarian Carcinosarcoma Associated with Cowden Syndrome-A Case Report]. Gan To Kagaku Ryoho. 2022 Jul;49(7):783–7. 19. Gupta S, Erickson LA. Renal Neoplasia in Cowden Syndrome. Mayo Clin Proc. 2020 Dec;95(12):2808–9. 20. Sugihara T, Mandai M, Koda M, Matono T, Nagahara T, Ueki M, et al. Cowden syndrome complicated with hepatocellular carcinoma possibly originating from non-alcoholic steatohepatitis (NASH). Hepatol Res. 2011 Feb;41(2):189–93. 21. Squarize CH, Castilho RM, Gutkind JS. Chemopre- vention and treatment of experimental Cowden’s dis- ease by mTOR inhibition with rapamycin. Cancer Res. 2008 Sep 1;68(17):7066–72. 22. Teng QX, Ashar YV, Gupta P, Gadee E, Fan YF, Reznik SE, et al. Revisiting mTOR inhibitors as anticancer agents. Drug Discov Today. 2019 Oct;24(10):2086–95. 23. Ghanavati M, Khorshidi Y, Shadnoush M, Akbari ME, Ardehali SH, Chavarri-Guerra Y, et al. Tamoxi- fen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-re- sponse meta-analysis. Cancer Rep (Hoboken). 2023 Apr;6(4):e1806. 24. Komiya T, Blumenthal GM, DeChowdhury R, Fiora- vanti S, Ballas MS, Morris J, et al. A Pilot Study of Si- rolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN. Oncologist. 2019 Dec;24(12):1510-e1265. 25. Ebrahimi N, Fardi E, Ghaderi H, Palizdar S, Khor- ram R, Vafadar R, et al. Receptor tyrosine kinase inhibitors in cancer. Cell Mol Life Sci. 2023 Mar 22;80(4):104. 26. Takayama T, Muguruma N, Igarashi M, Ohsumi S, Oka S, Kakuta F, et al. Clinical Guidelines for Diagnosis and Management of Cowden Syndrome/ PTEN Hamartoma Tumor Syndrome in Children and Adults-Secondary Publication. J Anus Rectum Colon. 2023;7(4):284–300.

Number 27 VOL. 27 (2), 2024	Number 27 VOL. 27 (1), 2024
Number 26 Number 26 VOL. 26(2), 2023 All in one	Number 26 VOL. 26(2), 2023
Number 26 VOL. 26, 2023 Supplement	Number 26 VOL. 26(1), 2023
Number 25 VOL. 25(2), 2022	Number 25 VOL. 25 (1), 2022
Number 24 VOL. 24(2), 2021	Number 24 VOL. 24(1), 2021
Number 23 VOL. 23(2), 2020	Number 22 VOL. 22(2), 2019
Number 22 VOL. 22(1), 2019	Number 22 VOL. 22, 2019 Supplement
Number 21 VOL. 21(2), 2018	Number 21 VOL. 21 (1), 2018
Number 21 VOL. 21, 2018 Supplement	Number 20 VOL. 20 (2), 2017
Number 20 VOL. 20 (1), 2017	Number 19 VOL. 19 (2), 2016
Number 19 VOL. 19 (1), 2016	Number 18 VOL. 18 (2), 2015
Number 18 VOL. 18 (1), 2015	Number 17 VOL. 17 (2), 2014
Number 17 VOL. 17 (1), 2014	Number 16 VOL. 16 (2), 2013
Number 16 VOL. 16 (1), 2013	Number 15 VOL. 15 (2), 2012
Number 15 VOL. 15, 2012 Supplement	Number 15 Vol. 15 (1), 2012
Number 14 14 - Vol. 14 (2), 2011	Number 14 The 9th Balkan Congress of Medical Genetics
Number 14 14 - Vol. 14 (1), 2011	Number 13 Vol. 13 (2), 2010
Number 13 Vol.13 (1), 2010	Number 12 Vol.12 (2), 2009
Number 12 Vol.12 (1), 2009	Number 11 Vol.11 (2),2008
Number 11 Vol.11 (1),2008	Number 10 Vol.10 (2), 2007
Number 10 10 (1),2007	Number 9 1&2, 2006
Number 9 3&4, 2006	Number 8 1&2, 2005
Number 8 3&4, 2004	Number 7 1&2, 2004
Number 6 3&4, 2003	Number 6 1&2, 2003
Number 5 3&4, 2002	Number 5 1&2, 2002
Number 4 Vol.3 (4), 2000	Number 4 Vol.2 (4), 1999
Number 4 Vol.1 (4), 1998	Number 4 3&4, 2001
Number 4 1&2, 2001	Number 3 Vol.3 (3), 2000
Number 3 Vol.2 (3), 1999	Number 3 Vol.1 (3), 1998
Number 2 Vol.3(2), 2000	Number 2 Vol.1 (2), 1998
Number 2 Vol.2 (2), 1999	Number 1 Vol.3 (1), 2000
Number 1 Vol.2 (1), 1999	Number 1 Vol.1 (1), 1998

About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact